Literature DB >> 9659500

Successful treatment of rhinocerebral mucormycosis by a combination of aggressive surgical debridement and the use of systemic liposomal amphotericin B and local therapy with nebulized amphotericin--a case report.

P Raj1, E J Vella, R C Bickerton.   

Abstract

A case of mucormycosis involving the nose and paranasal sinuses in a 55-year-old man with recently diagnosed acute promyelocytic leukaemia is reported. It was successfully treated with a combination of aggressive surgical debridement and systemic amphotericin B. In addition, local nebulized amphotericin B was used as an adjunct to therapy. We believe this is only the second documented use of nebulized amphotericin in the management of sinonasal mucormycosis. The need for a high index of suspicion and early aggressive management is emphasized.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9659500     DOI: 10.1017/s0022215100140484

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  8 in total

Review 1.  Zygomycosis: the re-emerging fungal infection.

Authors:  M Chayakulkeeree; M A Ghannoum; J R Perfect
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-04       Impact factor: 3.267

2.  Rhinocerebral mucormycosis: pathways of spread.

Authors:  Seid Mousa Sadr Hosseini; Peyman Borghei
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-05-13       Impact factor: 2.503

Review 3.  Current Treatment Options for COVID-19 Associated Mucormycosis: Present Status and Future Perspectives.

Authors:  Yasasve Madhavan; Kadambari Vijay Sai; Dilip Kumar Shanmugam; Aashabharathi Manimaran; Karthigadevi Guruviah; Yugal Kishore Mohanta; Divyambika Catakapatri Venugopal; Tapan Kumar Mohanta; Nanaocha Sharma; Saravanan Muthupandian
Journal:  J Clin Med       Date:  2022-06-23       Impact factor: 4.964

Review 4.  Current perspectives on ophthalmic mycoses.

Authors:  Philip A Thomas
Journal:  Clin Microbiol Rev       Date:  2003-10       Impact factor: 26.132

5.  Endogenous mycotic endophthalmitis in an immunocompetent patient.

Authors:  Pawan Gupta; Nishant Sachdev; Jasleen Kaur; Pranab Dey; Vishali Gupta; Amod Gupta
Journal:  Int Ophthalmol       Date:  2008-06-05       Impact factor: 2.031

6.  Mucormycosis in COVID-19 pandemic and its neurovascular spread.

Authors:  Pooja Pal; Bikramjit Singh; Sumant Singla; Rupinder Kaur
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-10-12       Impact factor: 3.236

7.  Functional Endoscopic Sinus Surgery and Recurrence of Post-COVID Mucormycosis.

Authors:  B M Rudagi; Jay Goyal; Chinmayee Palande; Prachi Patil
Journal:  J Maxillofac Oral Surg       Date:  2022-10-11

8.  Diabetes and rhino-orbito-cerebral mucormycosis - A deadly duo.

Authors:  Parminder Singh; Saurabh Arora; Naveen Mittal; Amroz Singh; Rohit Verma; Sarit Sharma; Neeraj Kumar Agrawal; Saloni Goyal
Journal:  J Diabetes Metab Disord       Date:  2021-01-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.